PUBLISHER: Acute Market Reports | PRODUCT CODE: 1510318
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1510318
Antiemetics Drugs Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032
The antiemetics drugs market refers to the segment of the pharmaceutical industry that focuses on the development, production, and sale of medications used to prevent and treat nausea and vomiting. These symptoms can be caused by various factors, including chemotherapy, radiation therapy, surgery, motion sickness, and gastrointestinal disorders. Antiemetics are crucial in managing these symptoms, improving patients' quality of life, and ensuring the effectiveness of other treatments, particularly in cancer therapy. The antiemetics drugs market is estimated to grow at a CAGR of 5.96% from 2024 to 2032.
The market is driven by the high prevalence of conditions that cause nausea and vomiting, especially in oncology. Cancer patients undergoing chemotherapy and radiation therapy often experience severe nausea and vomiting, which can lead to complications such as dehydration, electrolyte imbalances, and nutritional deficiencies. Antiemetics play a vital role in cancer care by enabling patients to continue their treatment regimens more comfortably. The market comprises various classes of antiemetics, including serotonin (5-HT3) receptor antagonists, dopamine antagonists, NK1 receptor antagonists, antihistamines, and cannabinoids. The development of new antiemetics focuses on enhancing efficacy, reducing side effects, and improving patient compliance. There is also a growing interest in developing treatments for refractory cases where traditional antiemetics are ineffective.
Additionally, the increasing adoption of multimodal treatment approaches, combining different classes of antiemetics to maximize efficacy, is a notable trend in the market. The global rise in healthcare expenditure and the growing emphasis on improving cancer care are also contributing to the market's growth. However, the market faces challenges, such as the need for drugs that can effectively manage the side effects of newer cancer treatments and the potential for side effects from the antiemetics themselves. Despite these challenges, the antiemetics drugs market plays a crucial role in supportive care in oncology and other medical fields.
Driver: Increasing Prevalence of Cancer and Chemotherapy-Induced Nausea and Vomiting (CINV)
The primary driver for the antiemetics drugs market is the increasing prevalence of cancer worldwide and the subsequent rise in chemotherapy treatments, which often lead to chemotherapy-induced nausea and vomiting (CINV). The global increase in cancer incidence, attributed to factors like aging populations and lifestyle changes, has resulted in a higher number of patients undergoing chemotherapy. CINV is one of the most common and distressing side effects of cancer chemotherapy, affecting a significant proportion of patients. The severity of CINV can lead to complications such as nutritional deficiencies, electrolyte imbalances, and decreased quality of life, making effective management with antiemetics essential. The demand for antiemetics is driven not only by the need to improve patient comfort but also to ensure adherence to chemotherapy regimens, thereby improving treatment outcomes.
Opportunity: Development of Novel Antiemetics and Combination Therapies
A significant opportunity in the antiemetics drugs market lies in the development of novel antiemetics and combination therapies. With the understanding that different antiemetics work through various mechanisms, there is an opportunity to develop new drugs that target unmet needs in nausea and vomiting management. Additionally, combination therapies, which use a mix of antiemetics, are becoming increasingly popular in managing CINV and postoperative nausea and vomiting (PONV). These combinations can be more effective than single-drug treatments and can help manage symptoms in patients who do not respond to traditional antiemetics.
Restraint: Side Effects and Efficacy Concerns of Antiemetics
However, the market faces a restraint in the form of side effects and efficacy concerns associated with antiemetics. While antiemetics are crucial in managing nausea and vomiting, they themselves can have side effects, ranging from mild to severe, including dizziness, headache, and constipation. Furthermore, there is a concern regarding the efficacy of antiemetics in completely controlling symptoms, particularly in patients with refractory or breakthrough vomiting. This restraint highlights the need for ongoing research and development to improve the safety and efficacy profile of antiemetics.
Challenge: Managing Refractory and Breakthrough Nausea and Vomiting
A major challenge in the antiemetics drugs market is effectively managing refractory and breakthrough nausea and vomiting. Refractory vomiting occurs when patients do not respond to standard antiemetic therapy, while breakthrough vomiting occurs despite prophylactic treatment. This challenge is significant as it affects patient quality of life and can lead to complications such as dehydration and hospital readmissions. Addressing this challenge involves not only developing more effective antiemetic drugs but also improving understanding of the pathophysiology of nausea and vomiting to tailor treatments to individual patient needs.
Market Segmentation by Drug Type
In the antiemetics drugs market, segmentation by drug type - Serotonin-receptor Antagonists, Anticholinergics, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, and Others (including Antihistamines, Cannabinoids) - reflects diverse growth rates and revenue streams. Serotonin-receptor antagonists, used primarily for chemotherapy-induced nausea and vomiting (CINV), hold the highest revenue share. Their dominance is attributed to their efficacy in controlling CINV, one of the most common and debilitating side effects of cancer treatment. These drugs, such as ondansetron and granisetron, work by blocking serotonin receptors in the brain and gut, preventing nausea and vomiting. Meanwhile, Neurokinin receptor antagonists are projected to exhibit the highest Compound Annual Growth Rate (CAGR). The growth in this segment is driven by the development of newer drugs targeting the NK1 receptor, which plays a key role in the vomiting reflex. These drugs, such as aprepitant, are often used in combination with other antiemetics for enhanced efficacy, particularly in treating CINV and postoperative nausea and vomiting (PONV).
Market Segmentation by Application
Concerning market segmentation by application - Chemotherapy, Gastroenteritis, Post Operative Surgery, Others - the chemotherapy segment commands the highest revenue. This is largely due to the high prevalence of cancer and the widespread use of chemotherapy, which often necessitates antiemetic treatment to manage its side effects. The effectiveness of antiemetics in improving patient adherence to chemotherapy regimens and enhancing their quality of life during treatment contributes to the segment's revenue dominance. On the other hand, the post-operative surgery segment is expected to witness significant growth in terms of CAGR. This anticipated growth can be attributed to the increasing number of surgical procedures globally and the rising awareness of the importance of managing PONV to improve patient recovery and satisfaction. The expansion of surgical procedures and the emphasis on enhanced recovery after surgery protocols are driving the demand for effective antiemetic treatments in this segment. The varied application of antiemetics across different medical conditions underscores their integral role in patient care in various healthcare settings.
Regional Insights
In the geographic segmentation of the antiemetics drugs market, distinct trends and growth potentials are observed across various regions. In 2023, North America, particularly the United States, held the highest revenue percentage in the market. This dominance was primarily due to the high prevalence of cancer, the extensive use of chemotherapy, and the well-established healthcare infrastructure supporting advanced cancer treatment protocols, including comprehensive nausea and vomiting management. Additionally, the presence of key pharmaceutical companies and high healthcare expenditure contributed to this region's leading position. However, from 2024 to 2032, the Asia-Pacific region is expected to exhibit the highest Compound Annual Growth Rate (CAGR). This expected growth can be attributed to the increasing incidence of cancer, expanding healthcare infrastructure, and rising awareness of effective nausea and vomiting management in countries like China and India. The growing healthcare sector and improving access to cancer treatments in these emerging economies are likely to drive the demand for antiemetics drugs.
Competitive Landscape
Regarding competitive trends and key players in the antiemetics drugs market, the landscape in 2023 was characterized by the presence of major pharmaceutical companies like GlaxoSmithKline, Pfizer, Merck & Co., Novartis, Cipla Inc., Eagle Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Astellas Pharma Inc., Glenmark Pharmaceuticals Ltd., Viatris Inc., and Baxter. These companies led the market with their extensive portfolios of antiemetics drugs, strong research and development capabilities, and global distribution networks. Their strategies in 2023 focused on innovation in drug development, targeting both efficacy and safety profiles, and addressing unmet needs in nausea and vomiting management. For the period from 2024 to 2032, these leading companies are expected to continue their focus on developing new and improved antiemetics, with an increased emphasis on targeting emerging markets and expanding indications for existing drugs. The market is also likely to witness a surge in strategic collaborations and partnerships, as companies aim to enhance their product offerings and strengthen their market positions. Additionally, emerging players in the market are expected to bring innovation, particularly in developing drugs for refractory and breakthrough nausea and vomiting. The competitive landscape is anticipated to evolve with a focus on addressing the diverse needs of patients across different geographical regions, with a continued emphasis on improving patient outcomes and adherence to cancer treatment regimens.
Historical & Forecast Period
This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Antiemetics Drugs market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users & consumption volume, price, and value.
Geographical revenues generated by countries considered in the report
Micro and macro environment factors that are currently influencing the Antiemetics Drugs market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.
Market Segmentation
Drug Type
- Serotonin-receptor Antagonists
- Anticholinergics
- Dopamine Receptor Antagonists
- Neurokinin Receptor Antagonists
- Others (Antihistamines, Cannabinoids)
Application
- Chemotherapy
- Gastroenteritis
- Post Operative Surgery
- Others
End-Use
- Hospital & Clinics
- Retail Pharmacy
- Others
Region Segment (2022-2032; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Antiemetics Drugs market?
What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2032.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Antiemetics Drugs market?
Which is the largest regional market for Antiemetics Drugs market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Antiemetics Drugs market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Antiemetics Drugs market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Antiemetics Drugs Market
- 2.2. Global Antiemetics Drugs Market, By Drug Type, 2023 (US$ Million)
- 2.3. Global Antiemetics Drugs Market, By Application, 2023 (US$ Million)
- 2.4. Global Antiemetics Drugs Market, By End-Use, 2023 (US$ Million)
- 2.5. Global Antiemetics Drugs Market, By Geography, 2023 (US$ Million)
- 2.6. Attractive Investment Proposition by Geography, 2023
3. Antiemetics Drugs Market: Competitive Analysis
- 3.1. Market Positioning of Key Antiemetics Drugs Market Vendors
- 3.2. Strategies Adopted by Antiemetics Drugs Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2023 Versus 2032
4. Antiemetics Drugs Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Antiemetics Drugs Market Value, 2022 - 2032, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
- 4.6. Porter's Five Force Model
- 4.6.1. Supplier Power
- 4.6.2. Buyer Power
- 4.6.3. Threat Of Substitutes
- 4.6.4. Threat Of New Entrants
- 4.6.5. Competitive Rivalry
- 4.7. PESTEL Analysis
- 4.7.1. Political Landscape
- 4.7.2. Economic Landscape
- 4.7.3. Technology Landscape
- 4.7.4. Legal Landscape
- 4.7.5. Social Landscape
5. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2023 Versus 2032
- 5.3. Market Segmentation
- 5.3.1. Serotonin-receptor Antagonists
- 5.3.2. Anticholinergics
- 5.3.3. Dopamine Receptor Antagonists
- 5.3.4. Neurokinin Receptor Antagonists
- 5.3.5. Others (Antihistamines, Cannabinoids)
6. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2023 Versus 2032
- 6.3. Market Segmentation
- 6.3.1. Chemotherapy
- 6.3.2. Gastroenteritis
- 6.3.3. Post Operative Surgery
- 6.3.4. Others
7. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 7.1. Market Overview
- 7.2. Growth & Revenue Analysis: 2023 Versus 2032
- 7.3. Market Segmentation
- 7.3.1. Hospital & Clinics
- 7.3.2. Retail Pharmacy
- 7.3.3. Others
8. North America Antiemetics Drugs Market, 2022-2032, USD (Million)
- 8.1. Market Overview
- 8.2. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 8.3. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 8.4. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 8.5.Antiemetics Drugs Market: By Region, 2022-2032, USD (Million)
- 8.5.1.North America
- 8.5.1.1. U.S.
- 8.5.1.1.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 8.5.1.1.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 8.5.1.1.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 8.5.1.2. Canada
- 8.5.1.2.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 8.5.1.2.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 8.5.1.2.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 8.5.1.3. Rest of North America
- 8.5.1.3.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 8.5.1.3.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 8.5.1.3.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 8.5.1.1. U.S.
- 8.5.1.North America
9. UK and European Union Antiemetics Drugs Market, 2022-2032, USD (Million)
- 9.1. Market Overview
- 9.2. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 9.3. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 9.4. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 9.5.Antiemetics Drugs Market: By Region, 2022-2032, USD (Million)
- 9.5.1.UK and European Union
- 9.5.1.1. UK
- 9.5.1.1.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 9.5.1.1.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 9.5.1.1.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 9.5.1.2. Germany
- 9.5.1.2.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 9.5.1.2.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 9.5.1.2.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 9.5.1.3. Spain
- 9.5.1.3.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 9.5.1.3.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 9.5.1.3.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 9.5.1.4. Italy
- 9.5.1.4.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 9.5.1.4.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 9.5.1.4.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 9.5.1.5. France
- 9.5.1.5.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 9.5.1.5.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 9.5.1.5.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 9.5.1.6. Rest of Europe
- 9.5.1.6.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 9.5.1.6.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 9.5.1.6.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 9.5.1.1. UK
- 9.5.1.UK and European Union
10. Asia Pacific Antiemetics Drugs Market, 2022-2032, USD (Million)
- 10.1. Market Overview
- 10.2. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 10.3. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 10.4. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 10.5.Antiemetics Drugs Market: By Region, 2022-2032, USD (Million)
- 10.5.1.Asia Pacific
- 10.5.1.1. China
- 10.5.1.1.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 10.5.1.1.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 10.5.1.1.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 10.5.1.2. Japan
- 10.5.1.2.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 10.5.1.2.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 10.5.1.2.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 10.5.1.3. India
- 10.5.1.3.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 10.5.1.3.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 10.5.1.3.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 10.5.1.4. Australia
- 10.5.1.4.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 10.5.1.4.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 10.5.1.4.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 10.5.1.5. South Korea
- 10.5.1.5.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 10.5.1.5.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 10.5.1.5.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 10.5.1.6. Rest of Asia Pacific
- 10.5.1.6.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 10.5.1.6.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 10.5.1.6.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 10.5.1.1. China
- 10.5.1.Asia Pacific
11. Latin America Antiemetics Drugs Market, 2022-2032, USD (Million)
- 11.1. Market Overview
- 11.2. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 11.3. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 11.4. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 11.5.Antiemetics Drugs Market: By Region, 2022-2032, USD (Million)
- 11.5.1.Latin America
- 11.5.1.1. Brazil
- 11.5.1.1.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 11.5.1.1.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 11.5.1.1.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 11.5.1.2. Mexico
- 11.5.1.2.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 11.5.1.2.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 11.5.1.2.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 11.5.1.3. Rest of Latin America
- 11.5.1.3.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 11.5.1.3.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 11.5.1.3.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 11.5.1.1. Brazil
- 11.5.1.Latin America
12. Middle East and Africa Antiemetics Drugs Market, 2022-2032, USD (Million)
- 12.1. Market Overview
- 12.2. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 12.3. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 12.4. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 12.5.Antiemetics Drugs Market: By Region, 2022-2032, USD (Million)
- 12.5.1.Middle East and Africa
- 12.5.1.1. GCC
- 12.5.1.1.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 12.5.1.1.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 12.5.1.1.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 12.5.1.2. Africa
- 12.5.1.2.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 12.5.1.2.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 12.5.1.2.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 12.5.1.3. Rest of Middle East and Africa
- 12.5.1.3.1. Antiemetics Drugs Market: By Drug Type, 2022-2032, USD (Million)
- 12.5.1.3.2. Antiemetics Drugs Market: By Application, 2022-2032, USD (Million)
- 12.5.1.3.3. Antiemetics Drugs Market: By End-Use, 2022-2032, USD (Million)
- 12.5.1.1. GCC
- 12.5.1.Middle East and Africa
13. Company Profile
- 13.1. GlaxoSmithKline
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
- 13.2. Pfizer, Merck & Co.
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
- 13.3. Novartis
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
- 13.4. Cipla Inc.
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
- 13.5. Eagle Pharmaceuticals, Inc.
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
- 13.6. Johnson & Johnson Services, Inc.
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
- 13.7. Astellas Pharma Inc.
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
- 13.8. Glenmark Pharmaceuticals Ltd
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
- 13.9. Viatris Inc.
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
- 13.10. Baxter
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
- 13.11. Other Notable Players
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 2 Global Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 3 Global Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 4 North America Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 5 North America Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 6 North America Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 7 U.S. Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 8 U.S. Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 9 U.S. Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 10 Canada Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 11 Canada Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 12 Canada Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 13 Rest of North America Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 14 Rest of North America Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 15 Rest of North America Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 16 UK and European Union Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 17 UK and European Union Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 18 UK and European Union Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 19 UK Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 20 UK Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 21 UK Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 22 Germany Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 23 Germany Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 24 Germany Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 25 Spain Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 26 Spain Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 27 Spain Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 28 Italy Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 29 Italy Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 30 Italy Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 31 France Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 32 France Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 33 France Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 34 Rest of Europe Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 35 Rest of Europe Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 36 Rest of Europe Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 37 Asia Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 38 Asia Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 39 Asia Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 40 China Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 41 China Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 42 China Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 43 Japan Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 44 Japan Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 45 Japan Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 46 India Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 47 India Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 48 India Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 49 Australia Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 50 Australia Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 51 Australia Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 52 South Korea Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 53 South Korea Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 54 South Korea Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 55 Latin America Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 56 Latin America Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 57 Latin America Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 58 Brazil Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 59 Brazil Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 60 Brazil Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 61 Mexico Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 62 Mexico Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 63 Mexico Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 64 Rest of Latin America Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 65 Rest of Latin America Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 66 Rest of Latin America Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 67 Middle East and Africa Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 68 Middle East and Africa Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 69 Middle East and Africa Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 70 GCC Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 71 GCC Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 72 GCC Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 73 Africa Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 74 Africa Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 75 Africa Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
- TABLE 76 Rest of Middle East and Africa Antiemetics Drugs Market By Drug Type, 2022-2032, USD (Million)
- TABLE 77 Rest of Middle East and Africa Antiemetics Drugs Market By Application, 2022-2032, USD (Million)
- TABLE 78 Rest of Middle East and Africa Antiemetics Drugs Market By End-Use, 2022-2032, USD (Million)
List of Figures
- FIG. 1 Global Antiemetics Drugs Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Antiemetics Drugs Market: Quality Assurance
- FIG. 5 Global Antiemetics Drugs Market, By Drug Type, 2023
- FIG. 6 Global Antiemetics Drugs Market, By Application, 2023
- FIG. 7 Global Antiemetics Drugs Market, By End-Use, 2023
- FIG. 8 Global Antiemetics Drugs Market, By Geography, 2023
- FIG. 9 Market Geographical Opportunity Matrix - Global Antiemetics Drugs Market, 2023
FIG. 10Market Positioning of Key Antiemetics Drugs Market Players, 2023
FIG. 11Global Antiemetics Drugs Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032
- FIG. 12 Global Antiemetics Drugs Market, By Drug Type, 2023 Vs 2032, %
- FIG. 13 Global Antiemetics Drugs Market, By Application, 2023 Vs 2032, %
- FIG. 14 Global Antiemetics Drugs Market, By End-Use, 2023 Vs 2032, %
- FIG. 15 U.S. Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 16 Canada Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 17 Rest of North America Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 18 UK Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 19 Germany Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 20 Spain Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 21 Italy Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 22 France Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 23 Rest of Europe Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 24 China Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 25 Japan Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 26 India Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 27 Australia Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 28 South Korea Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 29 Rest of Asia Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 30 Brazil Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 31 Mexico Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 32 Rest of Latin America Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 33 GCC Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 34 Africa Antiemetics Drugs Market (US$ Million), 2022 - 2032
- FIG. 35 Rest of Middle East and Africa Antiemetics Drugs Market (US$ Million), 2022 - 2032
